You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 151 No. 4, APRIL 1991 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  CLINICAL OBSERVATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (87)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Intravenous Methylphenidate Abuse

Prototype for Prescription Drug Abuse

Theodore Vandoren Parran, Jr, MD; Donald R. Jasinski, MD

Arch Intern Med. 1991;151(4):781-783.


Abstract



Data are presented from a case series of 22 patients who abused methylphenidate hydrochloride (Ritalin-SR). The abuse pattern and symptoms of toxicity were similar to that seen with cocaine hydrochloride and amphetamine sulfate addiction; yet, the morbidity and mortality seen in this case series were greater than usual for a group of patients involved in intravenous drug abuse. We describe the characteristics of the methylphenidate abuse syndrome in terms of the pharmacology of methylphenidate, the constituents of the Ritalin-SR preparation, and the disease of chemical dependence. We propose solutions to the problem of methylphenidate abuse.

(Arch Intern Med. 1991;151:781-783)



Author Affiliations



From the Department of Medicine, Francis Scott Key Medical Center and The Johns Hopkins University School of Medicine, Baltimore, Md. Dr Parran is now with St Vincent Charity Hospital and Case Western Reserve University School of Medicine, Cleveland, Ohio.


Footnotes



Accepted for publication December 7, 1989.

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Conditioned place preference and locomotor activity in response to methylphenidate, amphetamine and cocaine in mice lacking dopamine D4 receptors
Thanos et al.
J Psychopharmacol 2010;24:897-904.
ABSTRACT  

`ADHD patient' or `illicit drug user'? Managing medico-moral membership categories in drug dependence services
Schubert et al.
Discourse Society 2009;20:499-516.
ABSTRACT  

Methylphenidate-induced dendritic spine formation and {Delta}FosB expression in nucleus accumbens
Kim et al.
Proc. Natl. Acad. Sci. USA 2009;106:2915-2920.
ABSTRACT | FULL TEXT  

Applicability of the Dopamine and Rate Hypotheses in Explaining the Differences in Behavioral Pharmacology of the Chloro-Benztropine Analogs: Studies Conducted Using Intracerebral Microdialysis and Population Pharmacodynamic Modeling
Othman et al.
J. Pharmacol. Exp. Ther. 2007;322:760-769.
ABSTRACT | FULL TEXT  

Atomoxetine Versus Stimulants for Treatment of Attention Deficit/Hyperactivity Disorder
Gibson et al.
The Annals of Pharmacotherapy 2006;40:1134-1142.
ABSTRACT | FULL TEXT  

Use of methylphenidate in patients with cancer
Sood et al.
AM J HOSP PALLIAT CARE 2006;23:35-40.
ABSTRACT  

Methylphenidate inhibits cytochrome P450 in the Swiss Webster mouse
Le Nedelec and Rosengren
Hum Exp Toxicol 2002;21:273-280.
ABSTRACT  

Palliative Uses of Methylphenidate in Patients With Cancer: A Review
Rozans et al.
JCO 2002;20:335-339.
ABSTRACT | FULL TEXT  

Comparison between Intraperitoneal and Oral Methylphenidate Administration: A Microdialysis and Locomotor Activity Study
Gerasimov et al.
J. Pharmacol. Exp. Ther. 2000;295:51-57.
ABSTRACT | FULL TEXT  

How High a Dose of Stimulant Medication in Adult Attention Deficit Hyperactivity Disorder?
Sachdev and Trollor
Aust N Z J Psychiatry 2000;34:645-650.
ABSTRACT | FULL TEXT  

Ethylphenidate Formation in Human Subjects after the Administration of a Single Dose of Methylphenidate and Ethanol
Markowitz et al.
Drug Metab. Dispos. 2000;28:620-624.
ABSTRACT | FULL TEXT  

An evaluation of the abuse potential of modafinil using methylphenidate as a reference
Jasinski
J Psychopharmacol 2000;14:53-60.
ABSTRACT  

Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans
Volkow et al.
J Psychopharmacol 1999;13:337-345.
ABSTRACT  

Blockade of Striatal Dopamine Transporters by Intravenous Methylphenidate Is Not Sufficient to Induce Self-Reports of "High"
Volkow et al.
J. Pharmacol. Exp. Ther. 1999;288:14-20.
ABSTRACT | FULL TEXT  

Reviews : Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveats
Garland
J Psychopharmacol 1998;12:385-395.
ABSTRACT  

Is Methylphenidate Like Cocaine? Studies on Their Pharmacokinetics and Distribution in the Human Brain
Volkow et al.
Arch Gen Psychiatry 1995;52:456-463.
ABSTRACT  

Therapeutic Doses of Oral Methylphenidate Significantly Increase Extracellular Dopamine in the Human Brain
Volkow et al.
J. Neurosci. 2001;21:RC121-RC121.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.